Futura Medical PLC (OTCPK:FAMDF)

Full Year 2025 Futura Medical PLC Earnings Call Transcript

Apr 29, 2026 / 09:00 AM GMT

Release Date Price: $0.013 (-65.79%)

Transcript

Key Points

Positve

Futura Medical PLC (FAMDF) has developed a refreshed vision, strategy, and commercial model following a strategic review, positioning the company for future growth.
The company has made significant progress in the development of new products, including Iroxon Intense and WSD 4000, with plans for launch in 2027 and 2028 respectively.
Futura Medical PLC (FAMDF) has strengthened its balance sheet with a successful fundraise in December 2025, providing necessary working capital.
The company has a strong intellectual property position with patents granted or pending, protecting its innovative products until 2040.
There is a significant market opportunity for Futura Medical PLC (FAMDF)'s products, with a large percentage of the population experiencing symptoms that their products aim to address.

Negative

The financial performance in 2025 was disappointing, with a significant drop in revenue from 13.9 million in 2024 to 1.7 million in 2025.
The company reported a loss after tax of 9.1 million, including 4.1 million of exceptional items.
In-market sales of Iroxon were lower than expected across multiple regions, including the EU, UK, US, and Middle East.
There is a need for further funding, particularly for the WSD 4000 Phase 3 clinical trial, which could impact financial stability.
The company faces challenges in consumer repeat purchases due to factors like consumer over-expectation and imperfect understanding of product usage.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

FUM.L - Futura Medical PLC
Full Year 2025 Futura Medical PLC Earnings Call
Apr 29, 2026 / 09:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to the Futura Medical PLC for your results investor presentation. Throughout this recorded presentation, investors will be in listen-only mode. Questions are encouraged and they can be submitted at any time using the Q&A tab situated on the right-hand corner of your screen. Just simply type in your questions and press send. Before we begin, I would like to submit the following poll, and I would now like to hand you over to CEO Alex Duggan. Good morning.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning and a warm welcome to the Futura

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.